HIT (Health In Tech, Inc. Class A Common Stock) Stock Analysis - AI Report

Health In Tech, Inc. Class A Common Stock (HIT) is a publicly traded Technology sector company. As of May 21, 2026, HIT trades at $0.97 with a market cap of $68.81M and a P/E ratio of -50.95. HIT moved +2.97% today. Year to date, HIT is -40.24%; over the trailing twelve months it is +54.22%. Its 52-week range spans $0.51 to $7.59. Analyst consensus is buy with an average price target of $4.00. Rallies surfaces HIT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on HIT?

Rallies AI research for HIT combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

HIT Key Metrics

Key financial metrics for HIT
MetricValue
Price$0.97
Market Cap$68.81M
P/E Ratio-50.95
EPS$-0.02
Dividend Yield0.38%
52-Week High$7.59
52-Week Low$0.51
Volume671
Avg Volume0
Revenue (TTM)$34.08M
Net Income$-808.03K
Gross Margin58.95%

Latest HIT News

HIT Analyst Consensus

2 analysts cover HIT: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.00.

Common questions about HIT

What is the AI research view on HIT?
Rallies AI research for HIT combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for HIT?
Rallies AI research for HIT combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is HIT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for HIT. It does not provide personalized investment advice.
HIT

HIT